Doxirobe
Withdrawn
doxycycline
MedicineVeterinaryWithdrawn
The marketing authorisation for Doxirobe has not been renewed by the marketing authorisation holder and is now withdrawn.
Treatment of periodontal disease in dogs.
Periodontal pocket probing depths >=4 mm are evidence of disease that may be responsive to treatment with the Doxirobe Gel. Use of this product as directed should result in attachment level gains, periodontal pocket depth reductions, local antimicrobial effect and improved gingival health. Noticeable improvements in these parameters should be evident within 2-4 weeks following treatment. The response in individual dogs is dependent on the severity of the condition and rigor of adjunctive therapy.